Washington University School of Medicine: AI-based Breast Cancer Risk Technology Receives FDA Breakthrough Device Designation
July 30, 2025
July 30, 2025
ST. LOUIS, Missouri, July 30 -- The Washington University School of Medicine issued the following news release:
* * *
AI-based breast cancer risk technology receives FDA Breakthrough Device designation
Software developed at WashU Medicine on accelerated path to approval
*
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of developing breast ca . . .
* * *
AI-based breast cancer risk technology receives FDA Breakthrough Device designation
Software developed at WashU Medicine on accelerated path to approval
*
A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman's personalized five-year risk of developing breast ca . . .